KIAWAH ISLAND, S.C. — At the Kiawah Eye meeting here, John A. Hovanesian, MD, discusses how he uses a combination of higher add and lower add IOLs matched with patients’ desired vision to achieve better overall satisfaction.
Mid-Infrared Imaging Made Practical for Medicine by Danish Researchers
Different wavelengths of light reveal the world in unique ways, but some are hard to see using the human eye and modern imaging technologies. Mid-infrared light, for example, can be used to look at a variety of biological processes in the body, but it is hard to track when it’s used to film at a […]
FGX International Launches “Reading Glasses Day” with RestoringVision
SMITHFIELD, R.I.–(BUSINESS WIRE)–FGX International, a leading eyewear designer and marketer, is partnering with RestoringVision to launch the first Reading Glasses Day on June 7, 2019. Reading Glasses Day is a commemorative date dedicated to raising …
Ellavi, a Cheap Uterine Balloon Tamponade for Menstrual Bleeding, Wins EU Clearance
Postpartum hemorrhage (PPH) is one of the most common ways that new mothers do not survive childbirth. Although such severe, uncontrolled bleeding is extremely rare in the developed world, in places such as sub-Saharan Africa it is still pervasive. Ellavi, a uterine balloon tamponade (UBT) developed by Sinapi Biomedical, a company based in South Af (Read more...)
Iluvien delays recurrence of noninfectious posterior uveitis over 3 years
Three-year data for Iluvien found a single implant delayed recurrence of noninfectious posterior uveitis and reduced uveitis symptoms, according to a press release from Alimera Sciences.
The phase 3 clinical trial showed the median time to first recurrence of noninfectious uveitis affecting the posterior of the eye was 657 days, or 94 weeks, in patients treated with Iluvien (fluocinolone acetonide intravitreal implant 0.19 mg) compared with 70.5 days, or 10 weeks, in those treated with sham (P
Global Glaucoma Clinical Trial Pipeline Highlights, 2019 Report – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Glaucoma Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. Glaucoma Pipeline Highlights – 2019, provides most up-to-date information on key pipeline products in the global Glaucoma market. It covers emerging therapies for Glaucoma in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identi